Carl E Orringer
Overview
Explore the profile of Carl E Orringer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
4705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grant J, Orringer C
J Clin Lipidol
. 2024 Sep;
18(6):e882-e885.
PMID: 39304431
No abstract available.
2.
Grant J, Bokhari A, Manoharan A, Koester M, Dangl M, Martillo M, et al.
J Clin Lipidol
. 2024 Jun;
18(4):e610-e619.
PMID: 38908969
Background: Current guidelines recommend the reporting of incidental coronary artery calcification (CAC) on non-electrocardigram-gated computed tomography (CT) scans of the chest. The finding of incidental moderate or severe CAC on...
3.
4.
Ballantyne C, Minhas A, Orringer C
J Am Coll Cardiol
. 2023 Dec;
82(24):2262-2264.
PMID: 38057067
No abstract available.
5.
Grant J, Orringer C
Curr Atheroscler Rep
. 2023 Nov;
25(12):911-920.
PMID: 37971683
Purpose Of Review: To discuss and review the technical considerations, fundamentals, and guideline-based indications for coronary artery calcium scoring, and the use of other non-invasive imaging modalities, such as extra-coronary...
6.
7.
Grant J, Dangl M, Koester M, Tegegn M, Knijnik L, Singh H, et al.
J Clin Lipidol
. 2022 Sep;
16(5):608-616.
PMID: 36089503
Background: Non-Hispanic (NH) Black participants have been under-represented in studies of cardiovascular disease. Objective: We sought to determine the trends of reporting and representation of NH Black subjects in randomized...
8.
Wilson D, Jacobson T, Jones P, Koschinsky M, McNeal C, Nordestgaard B, et al.
J Clin Lipidol
. 2022 Sep;
16(5):e77-e95.
PMID: 36068139
Lipoprotein(a) [Lp(a)] is a well-recognized, independent risk factor for atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in 20% of the population. Observational and genetic evidence strongly support...
9.
Lloyd-Jones D, Morris P, Ballantyne C, Birtcher K, Covington A, DePalma S, et al.
J Am Coll Cardiol
. 2022 Aug;
80(14):1366-1418.
PMID: 36031461
No abstract available.
10.
Orringer C, Grant J, Tokgozoglu L
Curr Atheroscler Rep
. 2022 Aug;
24(11):839-847.
PMID: 36001213
Purpose Of Review: To provide a systematic approach to management of the patient with statin-attributed muscle symptoms. Recent Findings: We examined the prevalence of statin intolerance, the role of the...